Geovanny Perez

Dr. Geovanny Perez

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2015 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
GPGeovanny Perez
Geovanny Perez
KPKrishna Pancham
Krishna Pancham
SHShehlanoor Huseni
Shehlanoor Huseni
AJAmisha Jain
Amisha Jain
CRCarlos E. Rodriguez‐Martinez
Carlos E. Rodriguez‐Martinez
GNGustavo Nino
Gustavo Nino

19 September 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MGMaria Gutierrez
Maria Gutierrez
JGJose L Gomez
Jose L Gomez
GPGeovanny Perez
Geovanny Perez
KPKrishna Pancham
Krishna Pancham
SVStephanie Val
Stephanie Val
GNGustavo Nino
Gustavo Nino
Innate immune responses are fine-tuned by small noncoding RNA molecules termed microRNAs (miRs) that modify gene expression in response to the environment. During acute infections, miRs can be secreted in extracellular vesicles (EV) to facilitate cell-to-cell genetic communication. The purpose of this study was to characterize the baseline population of miRs secreted in EVs in the airways of young children (airway secretory microRNAome) and examine the changes during rhinovirus (RV) infection, the most common cause of asthma exacerbations and the most important early risk factor for the development of asthma beyond childhood. Nasal airway secretions were obtained from children (≤3 yrs. old) during PCR-confirmed RV infections (n = 10) and age-matched controls (n = 10). Nasal EVs were isolated with polymer-based precipitation and global miR profiles generated using NanoString microarrays. We validated our in vivo airway secretory miR data in an in vitro airway epithelium model using apical secretions from primary human bronchial epithelial cells (HBEC) differentiated at air-liquid interface (ALI). Bioinformatics tools were used to determine the unified (nasal and bronchial) signature airway secretory miRNAome and changes during RV infection in children. Multiscale analysis identified four signature miRs comprising the baseline airway secretory miRNAome: hsa-miR-630, hsa-miR-302d-3p, hsa- miR-320e, hsa-miR-612. We identified hsa-miR-155 as the main change in the baseline miRNAome during RV infection in young children. We investigated the potential biological relevance of the airway secretion of hsa-mir-155 using in silico models derived from gene datasets of experimental in vivo human RV infection. These analyses confirmed that hsa-miR-155 targetome is an overrepresented pathway in the upper airways of individuals infected with RV. Comparative analysis of the airway secretory microRNAome in children indicates that RV infection is associated with airway secretion of EVs containing miR-155, which is predicted in silico to regulate antiviral immunity. Further characterization of the airway secretory microRNAome during health and disease may lead to completely new strategies to treat and monitor respiratory conditions in all ages.

1 November 2016 in Journal of Microbiological Methods
Verified
Journal Article
Closed access
AHAndrea Hahn
Andrea Hahn
ASAmit Sanyal
Amit Sanyal
GPGeovanny Perez
Geovanny Perez
ACAnamaris M. Colberg-Poley
Anamaris M. Colberg-Poley
JCJoseph Campos
Joseph Campos
MPMarcos Perez-Losada
Marcos Perez-Losada

29 December 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GNGustavo Nino
Gustavo Nino
SHShehlanoor Huseni
Shehlanoor Huseni
GPGeovanny Perez
Geovanny Perez
KPKrishna Pancham
Krishna Pancham
HMHumaira Mubeen
Humaira Mubeen
MRMary C. Rose
Mary C. Rose
Thymic stromal lymphoproetin (TSLP) is a cytokine secreted by the airway epithelium in response to respiratory viruses and it is known to promote allergic Th2 responses in asthma. This study investigated whether virally-induced secretion of TSLP is directional in nature (apical vs. basolateral) and/or if there are TSLP-mediated effects occurring at both sides of the bronchial epithelial barrier in the asthmatic state. Primary human bronchial epithelial cells (HBEC) from control (n = 3) and asthmatic (n = 3) donors were differentiated into polarized respiratory tract epithelium under air-liquid interface (ALI) conditions and treated apically with dsRNA (viral surrogate) or TSLP. Sub-epithelial effects of TSLP were examined in human airway smooth muscle cells (HASMC) from normal (n = 3) and asthmatic (n = 3) donors. Clinical experiments examined nasal airway secretions obtained from asthmatic children during naturally occurring rhinovirus-induced exacerbations (n = 20) vs. non-asthmatic uninfected controls (n = 20). Protein levels of TSLP, CCL11/eotaxin-1, CCL17/TARC, CCL22/MDC, TNF-α and CXCL8 were determined with a multiplex magnetic bead assay. Our data demonstrate that: 1) Asthmatic HBEC exhibit an exaggerated apical, but not basal, secretion of TSLP after dsRNA exposure; 2) TSLP exposure induces unidirectional (apical) secretion of CCL11/eotaxin-1 in asthmatic HBEC and enhanced CCL11/eotaxin-1 secretion in asthmatic HASMC; 3) Rhinovirus-induced asthma exacerbations in children are associated with in vivo airway secretion of TSLP and CCL11/eotaxin-1. There are virally-induced TSLP-driven secretory immune responses at both sides of the bronchial epithelial barrier characterized by enhanced CCL11/eotaxin-1 secretion in asthmatic airways. These results suggest a new model of TSLP-mediated eosinophilic responses in the asthmatic airway during viral-induced exacerbations.

18 June 2015 in Pediatric Research
Verified
Journal Article
Open access
PDF file
KPKrishna Pancham
Krishna Pancham
GPGeovanny Perez
Geovanny Perez
SHShehlanoor Huseni
Shehlanoor Huseni
AJAmisha Jain
Amisha Jain
BKBassem Kurdi
Bassem Kurdi
GNGustavo Nino
Gustavo Nino
It is unknown why human metapneumovirus (HMPV) and respiratory syncytial virus (RSV) cause severe respiratory infection in children, particularly in premature infants. Our aim was to investigate if there are defective airway antiviral responses to these viruses in young children with history of prematurity. Nasal airway secretions were collected from 140 children ≤3 y old without detectable virus (n = 80) or with PCR-confirmed HMPV or RSV infection (n = 60). Nasal protein levels of IFNγ, CCL5/RANTES, IL-10, IL-4, and IL-17 were determined using a multiplex magnetic bead immunoassay. Full-term children with HMPV and RSV infection had increased levels of nasal airway IFNγ, CCL5, and IL-10 along with an elevation in Th1 (IFNγ)/Th2 (IL-4) ratios, which is expected during antiviral responses. In contrast, HMPV-infected premature children (< 32 wk gestation) did not exhibit increased Th1/Th2 ratios or elevated nasal airway secretion of IFNγ, CCL5, and IL-10 relative to uninfected controls. Our study is the first to demonstrate that premature infants have defective IFNγ, CCL5/RANTES, and IL-10 airway responses during HMPV infection and provides novel insights about the potential reason why HMPV causes severe respiratory disease in children with history of prematurity.

28 September 2017 in Pediatric Radiology
Verified
Journal Article
Closed access
PDF file
RNRazan Noorelahi
Razan Noorelahi
GPGeovanny Perez
Geovanny Perez
HOHansel J. Otero
Hansel J. Otero